Vermont Employment Growth Incentive

The DC Restaurant & Retail Stabilization Grant provides up to $50,000 in financial assistance to small restaurant and retail businesses in Washington, DC that experienced a revenue decline in 2025. Funded by the Office of the Deputy Mayor for Planning and Economic Development (DMPED) and administered by Capital Impact Partners — a local nonprofit community development financial institution — the program is a $3.875 million initiative designed to help brick-and-mortar businesses remain operational and support long-term sustainability. Grant funds may be used to cover occupancy costs and payroll over a six-month grant period. Preference is given to businesses that lost more than 10% of gross revenue in 2025, did not receive prior DMPED funding in 2023–2025, have a positive impact on the local community, and purchase goods or services from the DC, Maryland, or Virginia economy.

The Fast Track Job Training Assistance Program provides grants to new and expanding companies to support the training of new full-time employees. The amount of funding is based on the number of positions a business creates, the amount of capital it invests, and the compensation it pays its new employees.

The RCDI structure requires the intermediary (grantee) to provide a program of financial and technical assistance to recipients to develop their capacity and ability to undertake projects related to housing, community facilities, or community and economic development. The recipients will, in turn, provide programs that will support their communities (beneficiaries). The Intermediary will be required to provide matching funds in an amount at least equal to the RCDI grant. The respective minimum and maximum grant amount per Intermediary are $50,000 and $500,000.

This Notice of Funding Opportunity (NOFO) invites applications that propose to use mouse models to conduct rigorous preclinical testing of drugs or drug combinations currently used for other conditions, as well as investigational drugs at various stages of clinical development, predicted to be efficacious in AD/ADRD. This initiative will also support preclinical testing of repurposable or investigational drug candidates in combination with non-pharmacologic interventions leading to robust translational outcomes. The central goal is to establish robust proof of concept that will enable rational drug repurposing and combination therapy development for the treatment and prevention of AD/ADRD.

The MDC is offering a $500 Enhance MHT Grant to Manchester, NH businesses and landlords for improvements to streetscape, outdoor seating, restaurant barriers, façade improvement, window display, signage, or other related beautification efforts.